SCHEMBL625496

SCHEMBL625496

CC(C)(C)OC(=O)N1CCC2(CC1)CC(Nc1nn3cc(-c4cccc(OC(F)(F)F)c4)nc3s1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 4/20 0.39
IDH1 O75874 1/20 0.39
IDH2 P48735 1/20 0.39
ABHD6 Q9BV23 2/20 0.38
DAGLA Q9Y4D2 1/20 0.38
THRB P10828 2/20 0.37
PIM3 Q86V86 1/20 0.37
F2RL3 Q96RI0 2/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
TYRO3 Q06418 2/20 0.37
MAPT P10636 2/20 0.37
CDK9 P50750 1/20 0.36
KCNH2 Q12809 1/20 0.36
SCD5 Q86SK9 1/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL623873 0.90 IDH1 (0.44) PIM1IDH1IDH2ABHD6DAGLA
SCHEMBL623829 0.90 F2RL3 (0.48) IDH1IDH2F2RL3MAPTCDK9
SCHEMBL624454 0.89 PIM1 (0.45) PIM1ABHD6DAGLAPIM3F2RL3
SCHEMBL624037 0.86 CYP2D6 (0.39) IRAK4SCD5HSD17B10
SCHEMBL625296 0.86 F2RL3 (0.38) PIM1THRBPIM3F2RL3IRAK4
SCHEMBL625512 0.86 THRB (0.44) PIM1THRBF2RL3MAPTSCD5
SCHEMBL623722 0.85 PIM1 (0.43) PIM1THRBPIM3F2RL3IRAK4
SCHEMBL625495 0.84 PIM1 (0.46) PIM1PIM3KCNH2
SCHEMBL623996 0.84 THRB (0.42) PIM1THRBF2RL3IRAK4MAPT
SCHEMBL625561 0.84 PIM1 (0.49) PIM1PIM3F2RL3TYRO3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed